Market overview
The global enzyme linked immunosorbent assay market is worth USD 3.1 bn in 2026 and is forecast to reach USD 5.1 bn by 2036, growing at a 5.2% CAGR. United States is the largest country market and Assay kits is the largest by product segment.
| Scope | Enzyme-linked immunosorbent assay kits, reagents and plates used for diagnostics, research, and food and environmental testing. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 2.9 bn |
| Value 2026 | USD 3.1 bn |
| Value 2036 | USD 5.1 bn |
| CAGR 2026-2036 | 5.2% |
| Volume 2026 | 1,260 million tests |
| Volume 2036 | 1,990 million tests |
| Average price 2026 | USD 2.43 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Enzyme Linked Immunosorbent Assay market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 3.1 bn |
| 2027 | USD 3.2 bn |
| 2028 | USD 3.4 bn |
| 2029 | USD 3.6 bn |
| 2030 | USD 3.7 bn |
| 2031 | USD 3.9 bn |
| 2032 | USD 4.1 bn |
| 2033 | USD 4.4 bn |
| 2034 | USD 4.6 bn |
| 2035 | USD 4.8 bn |
| 2036 | USD 5.1 bn |
Enzyme Linked Immunosorbent Assay market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Assay kits | 62.0% | 63.9% | USD 1.9 bn | 5.5% |
| Reagents and consumables | 26.0% | 24.3% | USD 795 mn | 4.5% |
| Instruments and readers | 12.0% | 11.8% | USD 367 mn | 5.0% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Infectious disease diagnostics | 34.0% | 32.6% | USD 1.0 bn | 4.7% |
| Autoimmune and allergy testing | 16.0% | 16.8% | USD 490 mn | 5.7% |
| Oncology and endocrinology | 14.0% | 14.5% | USD 428 mn | 5.5% |
| Research and biopharma | 22.0% | 22.1% | USD 673 mn | 5.2% |
| Food and environmental | 14.0% | 14.1% | USD 428 mn | 5.2% |
By assay format
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Sandwich | 44.0% | 43.0% | USD 1.3 bn | 5.0% |
| Direct | 14.0% | 13.0% | USD 428 mn | 4.4% |
| Indirect | 22.0% | 22.0% | USD 673 mn | 5.2% |
| Competitive | 20.0% | 22.0% | USD 612 mn | 6.2% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Diagnostic laboratories | 34.0% | 33.0% | USD 1.0 bn | 4.9% |
| Hospitals | 22.0% | 21.0% | USD 673 mn | 4.7% |
| Pharma and biotech | 24.0% | 26.0% | USD 734 mn | 6.0% |
| Academic institutes | 20.0% | 20.0% | USD 612 mn | 5.2% |
By detection method
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Colorimetric | 52.0% | 44.0% | USD 1.6 bn | 3.5% |
| Fluorescent | 20.0% | 22.0% | USD 612 mn | 6.2% |
| Chemiluminescent | 28.0% | 34.0% | USD 857 mn | 7.3% |
Top 25 countries for enzyme linked immunosorbent assay by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.5% of 2026 revenue and the 25 countries below together hold 94.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 918 mn | 30.0% | USD 1.4 bn | 4.5% |
| 2 | China | USD 428 mn | 14.0% | USD 843 mn | 7.0% |
| 3 | Germany | USD 245 mn | 8.0% | USD 361 mn | 4.0% |
| 4 | Japan | USD 214 mn | 7.0% | USD 315 mn | 3.9% |
| 5 | France | USD 138 mn | 4.5% | USD 203 mn | 4.0% |
| 6 | United Kingdom | USD 122 mn | 4.0% | USD 188 mn | 4.4% |
| 7 | India | USD 122 mn | 4.0% | USD 290 mn | 9.0% |
| 8 | Italy | USD 107 mn | 3.5% | USD 157 mn | 3.9% |
| 9 | Brazil | USD 92 mn | 3.0% | USD 163 mn | 5.9% |
| 10 | South Korea | USD 76 mn | 2.5% | USD 132 mn | 5.6% |
| 11 | Spain | USD 43 mn | 1.4% | USD 67 mn | 4.4% |
| 12 | Canada | USD 43 mn | 1.4% | USD 67 mn | 4.4% |
| 13 | Mexico | USD 38 mn | 1.2% | USD 73 mn | 6.8% |
| 14 | Australia | USD 38 mn | 1.2% | USD 59 mn | 4.5% |
| 15 | Russia | USD 33 mn | 1.1% | USD 50 mn | 4.4% |
| 16 | Turkey | USD 33 mn | 1.1% | USD 63 mn | 6.8% |
| 17 | Netherlands | USD 27 mn | 0.9% | USD 42 mn | 4.5% |
| 18 | Switzerland | USD 27 mn | 0.9% | USD 42 mn | 4.5% |
| 19 | Poland | USD 22 mn | 0.7% | USD 34 mn | 4.4% |
| 20 | Taiwan | USD 22 mn | 0.7% | USD 34 mn | 4.4% |
| 21 | Thailand | USD 22 mn | 0.7% | USD 42 mn | 6.9% |
| 22 | Iran | USD 22 mn | 0.7% | USD 34 mn | 4.4% |
| 23 | Indonesia | USD 22 mn | 0.7% | USD 50 mn | 8.8% |
| 24 | Saudi Arabia | USD 22 mn | 0.7% | USD 42 mn | 6.9% |
| 25 | Belgium | USD 16 mn | 0.5% | USD 25 mn | 4.6% |
| Rest of world | USD 167 mn | 5.5% | USD 276 mn | 5.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Roche
- Revvity
- Siemens Healthineers
- Abbott
- Danaher
Group 2: Regional and specialist players
- Bio-Techne
- DiaSorin
- Merck KGaA
- Abcam
- Enzo Life Sciences
- Mabtech
- BioVendor
- Immunodiagnostic Systems
- RayBiotech
- Biomerica
Group 3: Emerging and niche players
- Elabscience
- Creative Diagnostics
- Boster Biological Technology
- Assay Genie
- Cusabio
- Abbexa
- MyBioSource
- Arigo Biolaboratories
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the enzyme linked immunosorbent assay market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.2% is calculated from the resulting values.
The market is divided by product, by application, by assay format, by end user, by detection method. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the enzyme linked immunosorbent assay market?
The global enzyme linked immunosorbent assay market is estimated at USD 2.9 bn in 2025 and USD 3.1 bn in 2026.
How fast will the enzyme linked immunosorbent assay market grow?
It is forecast to reach USD 5.1 bn by 2036, a compound annual growth rate of 5.2% from 2026, an increase of USD 2.0 bn.
Which country is the largest market for enzyme linked immunosorbent assay?
United States is the largest market by revenue at USD 918 mn in 2026, 30.0% of the global total. The three largest countries together hold 52.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.0% a year from 2026 to 2036.
Which enzyme linked immunosorbent assay segment is largest?
In the by product split, Assay kits is the largest segment with 62.0% of 2026 revenue.
Who are the leading enzyme linked immunosorbent assay companies?
Global leaders include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Revvity.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Continuous Positive Airway Pressure (CPAP)USD 3.1 bn · 6.5% CAGR
- Spray DryingUSD 3.0 bn · 5.3% CAGR
- Lyophilization EquipmentUSD 3.1 bn · 7.6% CAGR
- BiobankingUSD 3.2 bn · 8.5% CAGR
- CRISPR and Cas GeneUSD 2.9 bn · 13.5% CAGR
- Neurorehabilitation TechnologyUSD 3.4 bn · 9.0% CAGR
- Gene SynthesisUSD 2.8 bn · 15.0% CAGR
- CapsuleUSD 3.4 bn · 6.5% CAGR